WHO ICTRP trial
Transmission effect, invisible transmission mechanism and prevention and control…
ChiCTR2300073092 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300073092 |
|---|---|
| Public title | Transmission effect, invisible transmission mechanism and prevention and control strategies of asymptomatic colonization of carbapenem-resistant Enterobacteriaceae among ICU patients |
| Scientific title | Transmission effect, invisible transmission mechanism and prevention and control strategies of asymptomatic colonization of carbapenem-resistant Enterobacteriaceae among ICU patients |
| Primary sponsor | Second Affiliated Hospital of Anhui Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Carbapenem-resistant Enterobacteriaceae infection/colonization |
| Interventions | Intervention group;:Designed comprehensive measures for nosocomial infection prevention and control (including active screening of CRE, intensive disinfection and isolation, etc.) |
| Registration date | Jun 30, 2023 |
| Target size | Intervention group;:3000 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: